Clinical Utility and Prognostic Value of IDH Mutation in Gliomas Patients in Kurdistan Region: A Retrospective Comparative Analysis With Wild-Type Variants
Background:Isocitrate dehydrogenase (IDH) mutation has emerged as a key molecular biomarker in gliomas, with significant implications for diagnosis, classification, and prognosis under the WHO CNS5 framework. However, regional data from the Kurdistan Region of Iraq remain limited, particularly regarding its real-world...